Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System*
August 19, 2020
CARLSBAD, Calif. -- In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System* designed to enable a future in which turnaround times for next-generation sequencing (NGS) [...]
The Native Antigen Company Introduces Custom Service for Influenza Antigens
August 19, 2020
Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses Oxford, UK: The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today [...]
CELLINK HAS ENTERED INTO AN AGREEMENT TO ACQUIRE PRECISION DISPENSING COMPANY SCIENION AG
August 19, 2020
CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the owners of Scienion Ag (“Scienion”), a German life science company focusing on precision dispensing technologies, to acquire all shares for a purchase price on cash- and debt-free basis of 80M euros (the “Acquisition”). 40M euros will be paid in 2,814,032 newly issued shares of series [...]
CELLINK completes the acquisition of Scienion AG
August 19, 2020
As announced CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire the precision dispensing company Scienion AG. CELLINK has on this day completed the acquisition of all Scienion-shares. The purchase price, on cash- and debt-free basis, amounted to 80 MEUR, of which 40 MEUR was paid in 2,814,032 newly issued shares of series B [...]
QIAGEN expands integrated coronavirus NGS and software solutions to accelerate COVID-19 research
August 18, 2020
• QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing • QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research Hilden, Germany, and Germantown, Maryland – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with [...]
MGI Statement Regarding Patent Lawsuit in Hong Kong
August 18, 2020
Regarding the patent lawsuit initiated by Illumina against MGI in Hong Kong, the specific impact has yet to be determined. MGI believes that this patent litigation is an obvious attempt by Illumina to maintain a monopolistic market position and suppress the development of the industry. We intend to vigorously defend our intellectual property, and we have filed patent litigation against [...]
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
August 18, 2020
The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical new vaccines and biologics SAN DIEGO — Today, Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput DNA printing, announced the introduction of their next-generation platform, the BioXp™ 3250 [...]
Absolute Antibody Offers SARS-CoV-2 Neutralizing Antibodies Derived from COVID-19 Patients
August 18, 2020
Recombinant engineered antibodies available for coronavirus research and diagnostics Redcar, UK. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19. The antibodies, originally generated by Fred Hutchinson Cancer Research Center, have been engineered into recombinant formats useful for [...]
August 18, 2020
New program helps break down information barriers to cryo-EM adoption to speed development of more effective drugs HILLSBORO, Ore. -- Thermo Fisher Scientific, the world leader in serving science, today announced it is facilitating access to cryo-electron microscopy (cryo-EM) by directing pharmaceutical and biotechnology companies to contract research organizations (CROs) around the globe that offer [...]
Gemini Bio to Distribute Scinus Products in the United States
August 18, 2020
Gemini Bio adds Scinus Bioreactor to its portfolio WEST SACRAMENTO, CA and BILTHOVEN, The Netherlands – Gemini Bioproducts, LLC (“Gemini Bio”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Scinus Cell Expansion Netherlands [...]
